Leap Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 11/13/2025 | 5.32 M | $2.41 M | 0.00% | 12.83% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.44 M | $655.79 K | 451,295.63% | 3.49% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 1.24 M | $560.00 K | 0.00% | 2.99% |
| VANGUARD GROUP INC | 11/07/2025 | 1.16 M | $526.95 K | 0.00% | 2.80% |
| HIGHTOWER ADVISORS, LLC | 11/07/2025 | 1.10 M | $501.60 K | 0.73% | 2.67% |
| SIMPLIFY ASSET MANAGEMENT INC. | 10/20/2025 | 975.61 K | $442.93 K | 13.79% | 2.35% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 312.19 K | $141.82 K | 0.00% | 0.75% |
| JANE STREET GROUP, LLC | 11/14/2025 | 165.39 K | $75.09 K | 100.00% | 0.40% |
| KEY CLIENT FIDUCIARY ADVISORS, LLC | 10/14/2025 | 137.96 K | $62.63 K | -59.88% | 0.33% |
| STATE STREET CORP | 11/14/2025 | 125.61 K | $57.03 K | 0.00% | 0.30% |
| BLACKROCK, INC. | 11/12/2025 | 125.23 K | $56.86 K | 0.00% | 0.30% |
| HRT FINANCIAL LP | 11/14/2025 | 118.63 K | $53.00 K | 100.00% | 0.29% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 99.68 K | $45.26 K | 141.47% | 0.24% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 86.20 K | $39.13 K | 76.74% | 0.21% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 70.85 K | $32.17 K | 409.82% | 0.17% |
| NORTHERN TRUST CORP | 11/14/2025 | 61.61 K | $27.97 K | 0.00% | 0.15% |
| CITADEL ADVISORS LLC | 11/14/2025 | 36.80 K | $16.71 K | 100.00% | 0.09% |
| LPL FINANCIAL LLC | 11/12/2025 | 36.01 K | $16.35 K | -17.24% | 0.09% |
| CITADEL ADVISORS LLC | 11/14/2025 | 34.30 K | $15.57 K | -6.79% | 0.08% |
| XTX TOPCO LTD | 11/14/2025 | 30.66 K | $13.92 K | 118.59% | 0.07% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 25.83 K | $11.73 K | -35.30% | 0.06% |
| BAIRD FINANCIAL GROUP, INC. | 11/13/2025 | 20.00 K | $9.08 K | 0.00% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 12.20 K | $5.49 K | -4.69% | 0.03% |
| BLAIR WILLIAM & CO/IL | 11/12/2025 | 10.00 K | $4.54 K | 0.00% | 0.02% |
| SIMPLEX TRADING, LLC | 11/12/2025 | 5.05 K | $2.00 K | -1.94% | 0.01% |
| CNB BANK | 10/30/2025 | 5.00 K | $2.27 K | 0.00% | 0.01% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 3.81 K | $1.73 K | 0.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 1.88 K | $526 | 0.00% | 0.00% |
| HUNTINGTON NATIONAL BANK | 11/12/2025 | 1.00 K | $454 | 0.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 10/14/2025 | 1.00 K | $454 | 0.00% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 494 | $225 | -22.08% | 0.00% |
| UBS GROUP AG | 11/13/2025 | 400 | $182 | -99.67% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 227 | $103 | 0.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 12/02/2025 | 135 | $62 | 0.00% | 0.00% |
| TOMPKINS FINANCIAL CORP | 10/08/2025 | 120 | $54 | 0.00% | 0.00% |
| CALDWELL SUTTER CAPITAL, INC. | 10/29/2025 | 0 | $0 | -100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CIBC PRIVATE WEALTH GROUP, LLC | 11/24/2025 | 0 | $0 | -100.00% | 0.00% |
| BROKERS INTERNATIONAL FINANCIAL SERVICES, LLC. | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| DRW SECURITIES, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| FINANCIAL MANAGEMENT PROFESSIONALS, INC. | 10/15/2025 | 0 | $0 | -100.00% | 0.00% |
| MONACO ASSET MANAGEMENT SAM | 11/10/2025 | 0 | $0 | -100.00% | 0.00% |
| DAUNTLESS INVESTMENT GROUP, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Leap Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 47 institutional investors and hedge funds held shares of Leap Therapeutics, Inc.. The most heavily invested institutionals were:
GILEAD SCIENCES, INC.: 5.32 M
BANK OF AMERICA CORP /DE/: 1.44 M
ACADIAN ASSET MANAGEMENT LLC: 1.24 M
VANGUARD GROUP INC: 1.16 M
HighTower Advisors, LLC: 1.1 M
Simplify Asset Management Inc.: 975,608
30.61% of Leap Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 13.13 M shares in the last 24 months. This purchase volume represents approximately $7.00 M in transactions.